IIIV (IIIV)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9, Altman Z 4.1. Beneish M-Score of -2.15 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics present a stark dichotomy between robust profitability metrics and negligible capital efficiency. While the company demonstrates strong operational leverage with net margins at 8.4% and gross margins expanding to 68.8%, these gains are not translating into efficient returns on invested capital, as evidenced by an ROIC of merely 1.8%. The DuPont decomposition suggests that despite healthy margin expansion, either asset turnover is critically low or excessive leverage is failing to amplify the bottom line effectively. This inefficiency is underscored by a Piotroski F-Score of 5/9 and an Altman Z-Score of 4.1, indicating moderate financial distress risk rather than the safety margins typical of high-quality compounders. Conversely, the Beneish M-Score of -2.15 signals low earnings manipulation risk, suggesting that while profitability is real, its generation mechanism lacks capital discipline.
Valuation metrics reflect extreme market pricing relative to historical norms and sector peers, driven by an anticipated growth trajectory that appears disconnected from current capital deployment efficiency. The current price-to-earnings multiple of 272.8x implies the market is assigning a premium valuation based on future revenue growth expectations rather than present-day profitability or return characteristics. Given the ROIC-WACC spread is likely negative due to the low 1.8% ROIC, any fair value DCF model would struggle to justify this multiple unless implied long-term growth rates are exceptionally high, far exceeding typical industry averages for firms with such capital inefficiencies. The market appears willing to ignore current operational drag in exchange for potential future scaling, creating a significant gap between intrinsic value drivers and observed pricing.
The risk-reward profile is further complicated by the divergence between earnings quality indicators and return generation capabilities. While the low Beneish score provides some comfort regarding financial statement integrity, the combination of weak ROIC and a moderate Altman Z-Score introduces operational fragility that standard growth models may overlook. The 11.5% revenue growth YoY confirms top-line momentum but fails to address the core issue of capital allocation inefficiency highlighted by the sub-2% return on equity inputs. Investors must weigh whether the market is correctly pricing in a future transformation toward higher efficiency or if it remains exposed to downside risks associated with current operational metrics and potential financial distress triggers embedded in the Altman score.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XSW or VGT, the fund manager is mechanically forced to buy or sell IIIV shares regardless of IIIV's individual fundamentals. We estimate $14M of passive capital is structurally linked to IIIV through 2 tracked ETFs. Passive flows have a limited but growing influence on IIIV's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in IIIV to visualize passive redemption contagion across ETFs and collateral stocks.
If IIIV (IIIV) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA Corp. (NVDA) as the most exposed collateral stock, sharing 1 ETFs with IIIV. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
IIIV Ownership Dynamics
ETFs with Highest IIIV Exposure
Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
IIIV Capital Efficiency
How efficiently does IIIV convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
IIIV converts -10% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 110% reinvestment rate signals aggressive capacity expansion.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 868 | $18.89 | $16,396.52 |
| 2026-05-13 | 3,986 | $18.91 | $75,375.26 |
| 2026-05-12 | 2,252 | $20.17 | $45,422.84 |
| 2026-05-08 | 231 | $22.91 | $5,292.21 |
| 2026-05-07 | 770 | $22.00 | $16,940 |
| 2026-05-04 | 2,842 | $23.36 | $66,389.12 |
| 2026-04-30 | 790 | $22.39 | $17,688.1 |
| 2026-04-29 | 559 | $22.37 | $12,504.83 |
| 2026-04-27 | 372 | $21.58 | $8,027.76 |
| 2026-04-24 | 46 | $21.28 | $978.88 |
| 2026-04-22 | 207 | $22.28 | $4,611.96 |
| 2026-04-20 | 4,115 | $21.19 | $87,196.85 |
| 2026-04-17 | 95 | $21.04 | $1,998.8 |
| 2026-04-15 | 922 | $21.43 | $19,758.46 |
| 2026-04-14 | 70 | $20.83 | $1,458.1 |
| 2026-04-10 | 40 | $21.82 | $872.8 |
| 2026-04-09 | 11 | $22.14 | $243.54 |
| 2026-04-08 | 11 | $22.51 | $247.61 |
| 2026-04-07 | 634 | $22.62 | $14,341.08 |
| 2026-04-01 | 402 | $22.36 | $8,988.72 |
| 2026-03-31 | 2,493 | $22.90 | $57,089.7 |
| 2026-03-26 | 59 | $22.86 | $1,348.74 |
| 2026-03-24 | 3,042 | $22.38 | $68,079.96 |
| 2026-03-23 | 139 | $22.30 | $3,099.7 |
| 2026-03-20 | 311 | $22.56 | $7,016.16 |
| 2026-03-19 | 5,026 | $22.36 | $112,381.36 |
| 2026-03-18 | 3,479 | $22.81 | $79,355.99 |
| 2026-03-17 | 5,362 | $22.57 | $121,020.34 |
| 2026-03-16 | 6 | $23.19 | $139.14 |
| 2026-03-13 | 2,041 | $23.00 | $46,943 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare IIIV to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.